FDA DrugClass IINotable
FDA Recall: Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured f
Description
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Hazard
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Remedy
4,740 1,000-count bottles.
Related Recalls
2026-08-05 · FDA_DRUG
FDA Recall: Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack, Rx only, Manufactured by: Alkem
Ascend Laboratories, LLC
2026-08-05 · FDA_DRUG
FDA Recall: Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharma
Glenmark Pharmaceuticals Inc., USA
2026-08-05 · FDA_DRUG
FDA Recall: Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manuf
MICRO LABS USA INC
2026-08-05 · FDA_DRUG
FDA Recall: Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only,
MYLAN PHARMACEUTICALS INC